223 related articles for article (PubMed ID: 20868266)
21. 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.
Hughes K; Meek ME; Walker M; Beauchamp R
J Toxicol Environ Health B Crit Rev; 2003; 6(1):55-83. PubMed ID: 12587254
[TBL] [Abstract][Full Text] [Related]
22. Stereochemical aspects of 1,3-butadiene metabolism and toxicity in rat and mouse liver microsomes and freshly isolated rat hepatocytes.
Nieusma JL; Claffey DJ; Maniglier-Poulet C; Imiolczyk T; Ross D; Ruth JA
Chem Res Toxicol; 1997 Apr; 10(4):450-6. PubMed ID: 9114983
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism.
Elfarra AA; Krause RJ; Kemper RA
Chem Biol Interact; 2001 Jun; 135-136():239-48. PubMed ID: 11397394
[TBL] [Abstract][Full Text] [Related]
24. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
Sweeney LM; Himmelstein MW; Gargas ML
Chem Biol Interact; 2001 Jun; 135-136():303-22. PubMed ID: 11397398
[TBL] [Abstract][Full Text] [Related]
25. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
26. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study.
Albertini RJ; Srám RJ; Vacek PM; Lynch J; Nicklas JA; van Sittert NJ; Boogaard PJ; Henderson RF; Swenberg JA; Tates AD; Ward JB; Wright M; Ammenheuser MM; Binkova B; Blackwell W; de Zwart FA; Krako D; Krone J; Megens H; Musilová P; Rajská G; Ranasinghe A; Rosenblatt JI; Rössner P; Rubes J; Sullivan L; Upton P; Zwinderman AH
Res Rep Health Eff Inst; 2003 Jun; (116):1-141; discussion 143-62. PubMed ID: 12931846
[TBL] [Abstract][Full Text] [Related]
28. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
29. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Carcinogenesis; 1995 Aug; 16(8):1723-31. PubMed ID: 7634396
[TBL] [Abstract][Full Text] [Related]
30. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
31. Application of process chemistry and SAR modelling to the evaluation of health findings of lower olefins.
Bird MG; Lewis DF; Whitman FT; Lewis RJ; Przygoda RT; Witz G
Chem Biol Interact; 2001 Jun; 135-136():571-84. PubMed ID: 11397413
[TBL] [Abstract][Full Text] [Related]
32. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
33. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
34. An updated study of mortality among North American synthetic rubber industry workers.
Delzell E; Sathiakumar N; Graff J; Macaluso M; Maldonado G; Matthews R;
Res Rep Health Eff Inst; 2006 Aug; (132):1-63; discussion 65-74. PubMed ID: 17326338
[TBL] [Abstract][Full Text] [Related]
35. Comparative toxicity of dithiocarbamates and butadiene metabolites in human lymphoid and bone marrow cells.
Irons RD; Stillman WS; Pyatt DW; Yang Y; Le A; Gustafson DL; Hua Zheng J
Chem Biol Interact; 2001 Jun; 135-136():615-25. PubMed ID: 11397416
[TBL] [Abstract][Full Text] [Related]
36. Butadiene cancer exposure-response modeling: based on workers in the styrene-butadiene-rubber industry: total leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, and chronic myelogenous leukemia.
Sielken RL; Valdez-Flores C
Regul Toxicol Pharmacol; 2011 Aug; 60(3):332-41. PubMed ID: 21600953
[TBL] [Abstract][Full Text] [Related]
37. Genetic toxicity of 1,3-butadiene and styrene.
Norppa H; Sorsa M
IARC Sci Publ; 1993; (127):185-93. PubMed ID: 8070865
[TBL] [Abstract][Full Text] [Related]
38. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
39. 1,3-Butadiene working group report.
Adler ID; Cochrane J; Osterman-Golkar S; Skopek TR; Sorsa M; Vogel E
Mutat Res; 1995 Aug; 330(1-2):101-14. PubMed ID: 7623862
[TBL] [Abstract][Full Text] [Related]
40. Macromolecular adducts of butadiene.
Tretyakova NYu ; Lin YP; Upton PB; Sangaiah R; Swenberg JA
Toxicology; 1996 Oct; 113(1-3):70-6. PubMed ID: 8901884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]